Insufficient insulin secretion resulting from either loss of β cell mass in type 1 diabetes or β cell dysfunction in type 2 diabetes (T2D) manifests as hyperglycemia and contributes to increased morbidity and mortality (1). The gene discussed is INS; the disease is type 2 diabetes mellitus.